Inter Parfums (IPAR) Competitors

Inter Parfums (NASDAQ:IPAR) and Prestige Consumer Healthcare (NYSE:PBH) are both mid-cap consumer discretionary companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends, risk and community ranking.

Do insiders and institutionals hold more shares of IPAR or PBH?

55.6% of Inter Parfums shares are owned by institutional investors. Comparatively, 99.9% of Prestige Consumer Healthcare shares are owned by institutional investors. 43.9% of Inter Parfums shares are owned by company insiders. Comparatively, 1.6% of Prestige Consumer Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has more risk & volatility, IPAR or PBH?

Inter Parfums has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500.

Does the MarketBeat Community believe in IPAR or PBH?

Prestige Consumer Healthcare received 27 more outperform votes than Inter Parfums when rated by MarketBeat users. Likewise, 70.14% of users gave Prestige Consumer Healthcare an outperform vote while only 65.24% of users gave Inter Parfums an outperform vote.

Company	Underperform	Outperform
Inter Parfums	Outperform Votes 471 65.24%	Underperform Votes 251 34.76%
Prestige Consumer Healthcare	Outperform Votes 498 70.14%	Underperform Votes 212 29.86%

Does the media refer more to IPAR or PBH?

In the previous week, Prestige Consumer Healthcare had 3 more articles in the media than Inter Parfums. MarketBeat recorded 9 mentions for Prestige Consumer Healthcare and 6 mentions for Inter Parfums. Prestige Consumer Healthcare's average media sentiment score of 1.34 beat Inter Parfums' score of 0.87 indicating that Prestige Consumer Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inter Parfums	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Prestige Consumer Healthcare	7 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is IPAR or PBH a better dividend stock?

Inter Parfums pays an annual dividend of $3.20 per share and has a dividend yield of 2.3%. Prestige Consumer Healthcare pays an annual dividend of $1.90 per share and has a dividend yield of 2.2%. Inter Parfums pays out 62.3% of its earnings in the form of a dividend. Prestige Consumer Healthcare pays out 44.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Inter Parfums has increased its dividend for 4 consecutive years. Inter Parfums is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Is IPAR or PBH more profitable?

Prestige Consumer Healthcare has a net margin of 19.13% compared to Inter Parfums' net margin of 10.60%. Inter Parfums' return on equity of 16.34% beat Prestige Consumer Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inter Parfums	10.60%	16.34%	10.82%
Prestige Consumer Healthcare	19.13%	12.36%	6.39%

Do analysts recommend IPAR or PBH?

Inter Parfums presently has a consensus target price of $157.60, suggesting a potential upside of 11.94%. Prestige Consumer Healthcare has a consensus target price of $93.33, suggesting a potential upside of 9.64%. Given Inter Parfums' stronger consensus rating and higher probable upside, equities research analysts clearly believe Inter Parfums is more favorable than Prestige Consumer Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inter Parfums	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Prestige Consumer Healthcare	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Which has preferable earnings and valuation, IPAR or PBH?

Prestige Consumer Healthcare has lower revenue, but higher earnings than Inter Parfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Inter Parfums, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inter Parfums	$1.47B	3.08	$152.65M	$5.14	27.39
Prestige Consumer Healthcare	$1.14B	3.70	$209.34M	$4.29	19.84

Summary

Inter Parfums beats Prestige Consumer Healthcare on 12 of the 21 factors compared between the two stocks.